Ogasawara H, Middleton E Jr. Effect of selected flavonoids on histamine release (HR) and hydrogen peroxide (H2O2) generation by human leukocytes [abstract].
J Allergy Clin Immunol. 1985;75(suppl):184.
Middleton E Jr. Effect of flavonoids on basophil histamine release and other secretory systems.
Prog Clin Biol Res.
1986;213:493 - 506.
Yoshimoto T, Furukawa M, Yamamoto S, et al. Flavonoids: potent inhibitors of arachidonate 5-lipoxygenase.
Biochem Biophys Res Commun. 1983;116:612 - 618.
Shoskes DA, Zeitlin SI, Shahed A, et al. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial.
Urology.
1999;54:960 - 963.
Rodriguez LV, Janzen N, Raz S, et al. Treatment of interstitial cystitis with a quercetin containing compound: a preliminary, double-blind placebo control trial. Presented at: American Urological Association 2001 Annual Meeting; June 2 - 7, 2001; Anaheim, Calif.
Constant J. Alcohol, ischemic heart disease, and the French paradox.
Coron Artery Dis. 1997;8:645 - 649.
Hayek T, Fuhrman B, Vaya J. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation.
Arterioscler Thromb Vasc Biol. 1997;17:2744 - 2752.
Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol.
Lancet. 1993;341:1103 - 1104.
Alliangana DM. Effects of beta-carotene, flavonoid quercetin and quinacrine on cell proliferation and lipid peroxidation breakdown products in BHK-21 cells.
East Afr MedJ.
1996;73:752 - 757.
Keli SO, Hertog MG, Feskens EJ, et al. Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zupthen study.
Arch Intern Med.
1996;156:637 - 642.
Balasubramanian S, Govindasamy S. Inhibitory effect of dietary flavonol quercetin on 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis.
Carcinogenesis.
1996;17:877 - 879.
Cross HJ, Tilby M, Chipman JK, et al. Effect of quercetin on the genotoxic potential of cisplatin.
Int J Cancer. 1996;66:404 - 408.
Hoffman R, Graham L, Newlands ES. Enhanced anti-proliferative action of busulphan by quercetin on the human leukaemia cell line K562.
Br J Cancer. 1989;59:347 - 348.
ElAttar TM, Virji AS. Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation.
Anticancer Drugs.
1999;10:187 - 193.
Yoshida M, Yamamoto M, Nikaido T. Quercetin arrests human leukemic T-cells in late G
1
phase of the cell cycle.
Cancer Res.
1992;52:6676 - 6681.
Varma SD, Mizuno A, Kinoshita JH. Diabetic cataracts and flavonoids.
Science. 1977;195:205 - 206.
Kaul TN, Middleton E Jr, Ogra PL. Antiviral effect of flavonoids on human viruses.
J Med Virol. 1985;15:71 - 79.
Musci I, Pragai BM. Inhibition of virus multiplication and alteration of cyclic AMP level in cell cultures by flavonoids.
Experientia. 1985;41:930 - 931.
Stavric B. Quercetin in our diet: from potent mutagen to probable anticarcinogen.
Clin Biochem. 1994;27:245 - 248.
Friedman M, Smith GA. Factors which facilitate inactivation of quercetin mutagenicity.
Adv Exp Med Biol. 1984;177:527 - 544.
ElAttar TM, Virji AS. Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation.
Anticancer Drugs.
1999;10:187-193.
Strick R, Strissel PL, Borgers S, et al. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia.
Proc Natl Acad Sci. 2000;97:4790 - 4795.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.